|
Patients' inhaler switch hotly debated in court
New Zealand Doctor Online The Symbicort inhaler's ability to control, prevent and relieve asthma for some patients without the need for a separate reliever has been argued as meriting full funding by Pharmac. The rapid action of the Symbicort Turbuhaler makes a critical … Pharmac taken to court over asthma subsidy |
View full post on asthma – Google News